Kriya Therapeutics, Inc. — Form D/A

Kriya Therapeutics, Inc. of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2023-07-27. The offering totals $432.0M, of which $361.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Dana JohnsonExecutive OfficerPalo Alto, CA
James MomtazeeDirectorMenlo Park, CA
DANIEL CHENExecutive OfficerSan Mateo, CA
Neelaksh VarshneyDirectorMorrisville, NC
Michele StoneExecutive OfficerMorrisville, NC
Ilan OrenDirectorMorrisville, NC
Saira RamasastryDirectorRaleigh, NC
Ryan GallagherDirectorCorona Del Mar, CA
Keith ManchesterDirectorMorrisville, NC
Katherine EadeExecutive OfficerMorrisville, NC
Akshay RaiDirectorMorrisville, NC
Shankar RamaswamyDirectorMorrisville, NC
Shankar RamaswamyExecutive OfficerMorrisville, NC
Curt HerbertsExecutive OfficerMorrisville, NC
Britt PettyExecutive OfficerMorrisville, NC
Roger JeffsDirectorMorrisville, NC
Brian FurmanskiExecutive OfficerMorrisville, NC
Trit GargDirectorMorrisville, NC
Neera RavindranExecutive OfficerRedwood City, CA
Ilise LombardoExecutive OfficerRedwood City, CA
C.R. SincockDirectorRedwood City, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2025-09-10D/A$320.8M$320.8M
2025-08-15D$313.3M$313.3M
2022-05-24D$300.5M$270.5M
2021-07-14D$100.0M$100.0M
2020-08-18D/A$87.6M$87.6M
2020-05-19D$85.6M$85.6M

More